Impact and underlying mechanisms of osteoblast-derived exosomes on biological characteristics of prostate cancer cells

Jingyi LI; Jiajiu CHEN; Yaoming LI; Luofu WANG

doi:10.16016/j.2097-0927.202311002

您当前的位置：

首页 >

文章列表页 >

Impact and underlying mechanisms of osteoblast-derived exosomes on biological characteristics of prostate cancer cells

Basic Medicine | 更新时间：2026-01-09

- Impact and underlying mechanisms of osteoblast-derived exosomes on biological characteristics of prostate cancer cells
- Journal of Army Medical University Vol. 46, Issue 6, Pages: 544-555(2024)
- 作者机构：
  
  400042 重庆，陆军特色医学中心泌尿外科
- 作者简介：
- 基金信息：
  
  the National Natural Science Foundation for Young Scholars of China(81902600)
- DOI：10.16016/j.2097-0927.202311002
  CLC： R322.71;R363.21;R737.25
- Received：01 November 2023，
  
  Revised：2023-11-22，
  
  Published：30 March 2024
- 稿件说明：
移动端阅览
Jingyi LI, Jiajiu CHEN, Yaoming LI, et al. Impact and underlying mechanisms of osteoblast-derived exosomes on biological characteristics of prostate cancer cells[J]. Journal of Army Medical University, 2024, 46(6): 544-555.
DOI：

Jingyi LI, Jiajiu CHEN, Yaoming LI, et al. Impact and underlying mechanisms of osteoblast-derived exosomes on biological characteristics of prostate cancer cells[J]. Journal of Army Medical University, 2024, 46(6): 544-555. DOI： 10.16016/j.2097-0927.202311002.

摘要

目的

研究成骨细胞外泌体对前列腺癌细胞生物学特性的影响和潜在的机制。

方法

将人骨髓间充质干细胞诱导分化为成骨细胞，超速离心提取细胞培养基上清中的外泌体并鉴定。克隆形成试验分析成骨细胞外泌体对前列腺癌细胞增殖的影响。PCR芯片分析外泌体处理后前列腺癌细胞中表达变化的miRNA。通过荧光标记实验证明成骨细胞和肿瘤细胞中存在miRNA传递。在细胞和动物水平研究关键miRNA对前列腺癌细胞生物学特性的影响。生信分析并实验验证关键miRNA的靶基因。

结果

成功提取并鉴定了成骨细胞外泌体。相比于对照组，加入成骨细胞外泌体的前列腺癌细胞克隆形成能力明显增强(

0.05)。PCR芯片筛选发现miR-223可能是其中的关键分子。膜交换实验显示成骨细胞与前列腺癌细胞存在膜交换，FAM标记miRNA显示miR-223能够在细胞间传递。功能实验表明，过表达miR-223能够增强前列腺癌细胞的增殖、抗凋亡和迁移侵袭能力(

0.05)。生信分析提示WNT通路抑制蛋白APC可能是miR-223的靶基因，实验证实过表达miR-223能够降低前列腺癌细胞中APC的表达(

0.05)。Rescue实验显示过表达APC能够逆转miR-223对前列腺癌细胞增殖、迁移、侵袭的促进作用。

结论

成骨细胞外泌体是前列腺癌的促癌因子。外泌体中miR-223可能是其中的关键作用分子，其通过影响细胞中APC的表达发挥促癌作用。

Abstract

Objective

To investigate the effects and potential mechanisms of osteoblast-derived exosomes on the biological properties of prostate cancer (PC) cells.

Methods

Human bone marrow mesenchymal stem cells was induced to differentiate into osteoblasts

and then the exosomes were extracted from the supernatant of cell culture medium by ultracentrifugation and identified. Clone formation assay was employed to determine the effect of derived exosomes on the proliferation of PC cells

and PCR microarray was used to analyze miRNA changes after exosome treatment. Fluorescence labeling was applied to validate the transfer of miRNA between osteoblasts and tumor cells. The impact of key miRNA on the biological characteristics of PC cells was studied at the cellular and animal levels. Bioinformatics analysis was conducted to explore the target genes of key miRNA and then further validated.

Results

Osteoblast-derived exosomes were successfully extracted and then identified. These exosomes significantly promoted the clonogenic ability of PC cells when compared with the cells without treatment (

0.05). PCR microarray showed that miR-223 might be a key molecule in this process. Membrane exchange experiments demonstrated the presence of membrane exchange between osteoblasts and PC cells

and miRNA FAM labeling displayed that miR-223 was transferred within above cells. Functional experiments indicated that overexpression of miR-223 enhanced the proliferation

anti-apoptosis

and migration/invasion ability of PC cells (

0.05). Bioinformatics analysis indicated that APC

an inhibitor of WNT signaling pathway

may be a target gene of miR-223

which was further confirmed that overexpressing miR-223 down-regulated APC expression. Rescue experiment showed that overexpression of APC reversed the promoting effect of miR-223 on the proliferation

migration and invasion of PC cells.

Conclusion

Osteoblast-derived exosomes are pro-carcinogenic factors in PC

and miR-223 may be a key molecule in exosomes

which plays a oncogenic role by regulating APC in PC cells.

关键词

Keywords

references

ACHARD V, PUTORAP M, OMLIN A, et al . Metastatic prostate cancer: treatment options[J ] . Oncology, 2022, 100(1): 48-59. DOI: 10.1159/000519861.

GANGULY SS, LI X H, MIRANTI C K. The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis[J]. Front Oncol, 2014, 4: 364. DOI: 10.3389/fonc.2014.00364.

KALLURI R, LEBLEU V S. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478): eaau6977. DOI: 10.1126/science.aau6977.

SABER S H, ALI H E A, GABALLA R, et al . Exosomes are the driving force in preparing the soil for the metastatic seeds: lessons from the prostate cancer[J ] . Cells, 2020, 9(3): 564. DOI: 10.3390/cells9030564.

ZOU Z H, DAI RR, DENG N, et al . Exosomal miR-1275 secreted by prostate cancer cells modulates osteoblast proliferation and activity by targeting the SIRT2/RUNX2 cascade[J ] . Cell Transplant, 2021, 30: 9636897211052977. DOI: 10.1177/09636897211052977.

HASHIMOTO K, OCHI H, SUNAMURA S, et al . Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A[J ] . Proc Natl Acad Sci U S A, 2018, 115(9): 2204-2209. DOI: 10.1073/pnas.1717363115.

LIU Y, YANG C M, CHEN SS, et al . Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway[J ] . Cancer Gene Ther, 2023, 30(3): 437-449. DOI: 10.1038/s41417-022-00563-1.

COUGHLAN C, BRUCE K D, BURGY O, et al . Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses[J ] . Curr Protoc Cell Biol, 2020, 88(1): e110. DOI: 10.1002/cpcb.110.

LI J H, LIU S, ZHOU H, et al . starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data[J ] . Nucle ic Acids Res, 2014, 42(Database issue): D92-D97. DOI: 10.1093/nar/gkt1248.

SHEN W T, SONG Z G, ZHONG X, et al . Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform[J ] . iMeta, 2022, 1(3): e36. DOI: 10.1002/imt2.36.

SUNG H, FERLAY J, SIEGEL R L, et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.

FORNETTI J, WELM A L, STEWART S A. Understanding the bone in cancer metastasis[J]. J Bone&Mineral Res, 2018, 33(12): 2099-2113. DOI: 10.1002/jbmr.3618.

HOSHINO A, COSTA-SILVA B, SHEN T L, et al . Tumour exosome integrins determine organotropic metastasis[J ] . Tumour exosome integrins determine organotropic metastasis. Nature. 2015, 527(7578): 329-335. DOI: 10.1038/nature15756.

POLAVARAM N S, DUTTA S, ISLAM R, et al . Tumor-and osteoclast-derived NRP2 in prostate cancer bone metastases[J ] . Bone Res, 2021, 9(1): 24. DOI: 10.1038/s41413-021-00136-2.

KONG D P, YE C, ZHANG C X, et al . Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer[J ] . J Exp Clin Cancer Res, 2023, 42(1): 45. DOI: 10.1186/s13046-023-02610-7.

ZHANG X Y. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer[J]. Cancer Commun (Lond), 2019, 39(1): 76. DOI: 10.1186/s40880-019-0425-1.

YU-LEE L Y, YU G Y, LEE Y C, et al . Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFβRIII-p38MAPK-pS249/T252RB pathway[J ] . Cancer Res, 2018, 78(11): 2911-2924. DOI: 10.1158/0008-5472.CAN-17-1051.

VALADI H, EKSTRÖM K, BOSSIOS A, et al . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells[J ] . Nat Cell Biol, 2007, 9(6): 654-659. DOI: 10.1038/ncb1596.

PONZETTI M, RUCCI N. Switchinghomes: how cancer moves to bone[J]. Int J Mol Sci, 2020, 21(11): 4124. DOI: 10.3390/ijms21114124.

IM E J, LEE C H, MOON P G, et al . Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A[J ] . Nat Commun, 2019, 10(1): 1387. DOI: 10.1038/s41467-019-09387-4.

MELO S A, SUGIMOTO H, O'CONNELL J T, et al . Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis[J ] . Cancer Cell, 2014, 26(5): 707-721. DOI: 10.1016/j.ccell.2014.09.005.

CHENG L, SHARPLES R A, SCICLUNA B J, et al . Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood[J ] . J Extracell Vesicles, 2014, 3: (1): 23743. DOI: 10.3402/jev.v3.23743.

LI B W, CAO Y, SUN M J, et al . Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy[J ] . FASEB J, 2021, 35(10): e21916. DOI: 10.1096/fj.202100294RR.

HAN L Z, LI Z G, JIANG Y Q, et al . SNHG29 regulates miR-223-3p/CTNND1 axis to promote glioblastoma progression via Wnt/β-catenin signaling pathway[J ] . Cancer Cell Int, 2019, 19: 345. DOI: 10.1186/s12935-019-1057-x.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰